168 related articles for article (PubMed ID: 25327822)
1. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo.
Shanehsazzadeh S; Gruettner C; Lahooti A; Mahmoudi M; Allen BJ; Ghavami M; Daha FJ; Oghabian MA
Contrast Media Mol Imaging; 2015; 10(3):225-36. PubMed ID: 25327822
[TBL] [Abstract][Full Text] [Related]
2. Detection of MUC1-expressing ovarian cancer by C595 monoclonal antibody-conjugated SPIONs using MR imaging.
Shahbazi-Gahrouei D; Abdolahi M
ScientificWorldJournal; 2013; 2013():609151. PubMed ID: 24194685
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-targeted ultra-small superparamagnetic iron oxide particles for magnetic resonance molecular imaging of lung cancer cells in vitro.
Chen CL; Hu GY; Mei Q; Qiu H; Long GX; Hu GQ
Chin Med J (Engl); 2012 Jul; 125(13):2322-8. PubMed ID: 22882856
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
[TBL] [Abstract][Full Text] [Related]
5. Development and
Ma XH; Wang S; Liu SY; Chen K; Wu ZY; Li DF; Mi YT; Hu LB; Chen ZW; Zhao XM
World J Gastroenterol; 2019 Jun; 25(24):3030-3043. PubMed ID: 31293339
[TBL] [Abstract][Full Text] [Related]
6. Bismuth-213 radioimmunotherapy with C595 anti-MUC1 monoclonal antibody in an ovarian cancer ascites model.
Song EY; Qu CF; Rizvi SM; Raja C; Beretov J; Morgenstern A; Apostolidis C; Bruchertseifer F; Perkins A; Allen BJ
Cancer Biol Ther; 2008 Jan; 7(1):76-80. PubMed ID: 18347423
[TBL] [Abstract][Full Text] [Related]
7. MUC-1 aptamer targeted superparamagnetic iron oxide nanoparticles for magnetic resonance imaging of pancreatic cancer in vivo and in vitro experiment.
Zou Q; Zhang CJ; Yan YZ; Min ZJ; Li CS
J Cell Biochem; 2019 Nov; 120(11):18650-18658. PubMed ID: 31338877
[TBL] [Abstract][Full Text] [Related]
8. Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superparamagnetic iron oxide particles with magnetic resonance imaging.
Liu D; Chen C; Hu G; Mei Q; Qiu H; Long G; Hu G
Acta Biochim Biophys Sin (Shanghai); 2011 Apr; 43(4):301-6. PubMed ID: 21345916
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-Labeled Iron Oxide Nanoparticles for Dual-Contrast (T1/T2) Magnetic Resonance and Dual-Modality Imaging of Tumor Angiogenesis.
Xue S; Zhang C; Yang Y; Zhang L; Cheng D; Zhang J; Shi H; Zhang Y
J Biomed Nanotechnol; 2015 Jun; 11(6):1027-37. PubMed ID: 26353592
[TBL] [Abstract][Full Text] [Related]
10. Development of SM5-1-conjugated ultrasmall superparamagnetic iron oxide nanoparticles for hepatoma detection.
Kou G; Wang S; Cheng C; Gao J; Li B; Wang H; Qian W; Hou S; Zhang D; Dai J; Gu H; Guo Y
Biochem Biophys Res Commun; 2008 Sep; 374(2):192-7. PubMed ID: 18621023
[TBL] [Abstract][Full Text] [Related]
11. Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model.
Wang L; Chen H; Pourgholami MH; Beretov J; Hao J; Chao H; Perkins AC; Kearsley JH; Li Y
PLoS One; 2011; 6(9):e24405. PubMed ID: 21931707
[TBL] [Abstract][Full Text] [Related]
12. [Construction of RGD10-NGR9 dual-targeting superparamagnetic iron oxide and its magnetic resonance imaging features in nude mice].
Wu QY; Shi JY; Zhang J; Zhang LQ; Zhao YM; Tang L; Chen Y; He XD; Liu H; Su B
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):808-13. PubMed ID: 24447476
[TBL] [Abstract][Full Text] [Related]
13. Integrin α
Li D; Dong C; Ma X; Zhao X
Cancer Imaging; 2021 Jun; 21(1):44. PubMed ID: 34187570
[TBL] [Abstract][Full Text] [Related]
14. Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core.
Bashford JL; Robins RA; Price MR
Int J Cancer; 1993 Jul; 54(5):778-83. PubMed ID: 7686886
[TBL] [Abstract][Full Text] [Related]
15. A new radiopharmaceutical compound (131I-PR81) for radioimmunotherapy of breast cancer: labeling of antibody and its quality control.
Mohammadnejad J; Rasaee MJ; Babaei MH; Paknejad M; Zahir MH; Salouti M; Rajabi AB; Mazidi M
Hum Antibodies; 2010; 19(4):79-88. PubMed ID: 21178279
[TBL] [Abstract][Full Text] [Related]
16. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
[No Abstract] [Full Text] [Related]
17. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
18. Anti-CXCR4 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles in an application of MR molecular imaging of pancreatic cancer cell lines.
He Y; Song W; Lei J; Li Z; Cao J; Huang S; Meng J; Xu H; Jin Z; Xue H
Acta Radiol; 2012 Nov; 53(9):1049-58. PubMed ID: 23012484
[TBL] [Abstract][Full Text] [Related]
19. Specific targeting of breast tumor by octreotide-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 3.0-Tesla magnetic resonance scanner.
Li X; Du X; Huo T; Liu X; Zhang S; Yuan F
Acta Radiol; 2009 Jul; 50(6):583-94. PubMed ID: 19449236
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Evaluation of Gd(3+)-Anionic Linear Globular Dendrimer-Monoclonal Antibody: Potential Magnetic Resonance Imaging Contrast Agents for Prostate Cancer Cell Imaging.
Mirzaei M; Mehravi B; Ardestani MS; Ziaee SA; Pourghasem P
Mol Imaging Biol; 2015 Dec; 17(6):770-6. PubMed ID: 25917749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
